This Solicitation opportunity from Government of Canada was posted on April 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Supply and Delivery of Drugs and Placebo for the CATIS-ICAS Research Study

Closed

HHS0674 [BF-104767]International

Submission Closed05/01/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

SUNSCREEN PREPARATION

Solicitation # SPE2DP-26-T-4964

This contract is for the procurement of SPF 50 sunscreen preparation for the Department of Defense, specifically for delivery to the USS Paul Hamilton. The product must be an over-the-counter topical preparation containing 4.5 percent titanium dioxide and 4 percent zinc oxide. It is required to be hypoallergenic, oil-free, PABA-free, biodegradable, and water-resistant for 80 minutes. The order consists of 10 packages, with each package containing 24 three-ounce tubes. The sunscreen must have a total shelf life of 24 months, with at least 21 months remaining upon receipt. Storage requirements specify a cool, dry place between 15 and 30 degrees Celsius. Packaging must adhere to commercial standards and Medical Marking Standard No. 1, with specific shipping instructions for vessel delivery. The delivery timeline is set for 20 days after the order, with a required delivery date of September 11, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM HYPOCHLORITE SO

Solicitation # SPE2DP-26-T-4965

This contract is for the procurement of one 16 oz bottle of dental sodium hypochlorite solution, identified by NSN 6505016726659. The item is subject to a non-extendable 12-month shelf life and must be stored in a cool, dry, and well-ventilated area. Delivery is required within 20 days to the USS Portland LPD 27 via DLA Distribution San Diego. The supplier must comply with strict hazardous material guidelines, including the submission of Safety Data Sheets and labels consistent with OSHA and 29 C.F.R. 1910.1200 standards. Packaging and marking must adhere to Medical Marking Standard No. 1 and DLA packaging requirements, with specific instructions for hazardous materials under TQ requirement IP025 or commercial packaging via ASTM D3951.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4853

This contract is for the procurement of Sodium Nitroprusside, USP, an FDA-regulated drug for intravenous infusion. The item is supplied in single-dose fliptop vials containing 2 ml of solution with a strength of 25 mg per ml. The order consists of 20 vials under NSN 6505-01-657-1391, with a non-extendable shelf life of 24 months. The product must be stored at controlled room temperature between 20 and 25 degrees Celsius and protected from light in its original carton. Delivery is set for Fort Stewart, Georgia, with a required delivery date of September 3, 2026, and a delivery window of 20 days. The contractor must adhere to DLA packaging requirements and Medical Marking Standard No. 1 for all labeling and marking. Shipping must be conducted via traceable means, and the contract specifies that the material must be properly sealed in suitable containers to prevent damage during transit.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4967

This contract is for the procurement of Iohexol Injection, a radiological contrast medium with a concentration of 300mg/ml. The order consists of two boxes, each containing ten 150ml polymer bottles. The product must be stored at a controlled room temperature between 20 and 25 degrees Celsius and must be protected from strong daylight and freezing. It carries a non-extendable shelf life of 36 months. The supplier must adhere to DLA packaging and medical marking standards, ensuring all units are sealed and protected from damage. Because the material may be classified as hazardous, the contractor is required to submit Safety Data Sheets and Hazardous Communication Standard labels for approval prior to the award. Delivery is set for the USS Somerset (LPD 25) via the fastest traceable means, with a required delivery date of September 11, 2026, and a delivery window of 20 days.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4896

This contract, solicitation number SPE2DP-26-T-4896, is issued by the Department of Defense Medical Supply Chain Pharm FSA for the procurement of Iohexol Injection, USP. The requirement is for one box of 300mg/ml contrast media, provided in 150ml polymer bottles in a 10-pack configuration. The product must be sourced from GE Healthcare Inc and adheres to a non-extendable shelf life of 36 months. Storage requirements specify a controlled room temperature between 20 and 25 degrees Celsius, with protection from strong daylight and direct sunlight. The procurement is governed by NAICS code 424210 and requires compliance with DLA packaging requirements, specifically Medical Marking Standard No. 1 and RP001. Suppliers must provide Safety Data Sheets and Hazardous Communication Standard labels in accordance with OSHA and Federal Standard No. 313-E. Delivery is set for the Naval Med Readiness Logistics Command in Williamsburg, Virginia, with a required delivery date of September 4, 2026, and a delivery window of five days after receipt of order. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MICONAZOLE NITRATE POW

Solicitation # SPE2DP-26-T-4835

This contract, solicitation SPE2DP-26-T-4835, is issued by the Department of Defense Medical Supply Chain Pharm FSA for the procurement of Miconazole Nitrate antifungal foot powder. The requirement is for 300 cases of 3-ounce powder, with each case containing 12 units. This is a Total Small Business Set-Aside under NAICS code 424210. The product is FDA regulated and must be stored at controlled room temperature in a cool, dry place away from incompatible products. It carries a non-extendable shelf life of 24 months and must be marked according to Medical Marking Standard No. 1. The contract specifies delivery to Fort Sill, Oklahoma, with a required delivery date of September 3, 2026, and a delivery window of 20 days. Suppliers must comply with DLA packaging requirements, including MIL-STD-129 for labeling and RP001 for palletization. Because the material may be hazardous, suppliers are required to submit Safety Data Sheets and Hazardous Communication Standard labels in accordance with 29 C.F.R. 1910.1200 prior to the award. Inspection and acceptance will take place at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Pharmaceutical Distribution Services

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Personal Hygiene Consumables Supplier

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Supply of Ondansetron Injection, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ALBUTEROL SULFATE AND

Solicitation # SPE2DP-26-Q-0130

This contract, solicitation number SPE2DP-26-Q-0130, is a firm fixed price agreement for the procurement of Albuterol Sulfate and Ipratropium Bromide inhalation solution (NSN 6505-01-696-1961). The medication is supplied as a 3-ml sterile solution for nebulization in unit-dose vials, with each box containing 60 vials. It is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator. The product has a non-extendable shelf life of 18 months and must be stored between 2 and 25 degrees Celsius and protected from light. The procurement consists of three line items totaling 13 boxes, with delivery scheduled for 7 days after the order. Shipments are destined for medical logistics facilities at Fort Bragg, North Carolina, and Fort Stewart, Georgia. Packaging must meet commercial standards and be marked according to Medical Marking Standard No. 1, ensuring each unit is in a sealed container to prevent damage. All shipments must be sent via traceable means, and palletization must adhere to DLA packaging requirements. Inspection and acceptance occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BISMUTH SUBSALICYLATE

Solicitation # SPE2DP-26-Q-0132

Solicitation SPE2DP-26-Q-0132, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, seeks quotes for Bismuth Subsalicylate Tablets (NSN 6505-01-244-8010). The requirement consists of two line items: 6 packages for the first delivery and 4 packages for the second, both with a firm fixed price and a delivery window of 15 days after receipt of order. The tablets are sugar-free, over-the-counter, and each contains 262 mg of bismuth subsalicylate and 140 mg of calcium. Each package contains 48 individually sealed tablets. The product has a total shelf life of 36 months, with a minimum of 31 months remaining at the time of receipt by the government. Storage requires avoiding excessive heat over 104 degrees Fahrenheit. Packaging and labeling must adhere to Medical Marking Standard No. 1A and DLA packaging requirements, with specific instructions for hazardous and non-hazardous materials. Delivery and acceptance points are at the destination, with shipping addresses located at Rose Barracks in Vilseck, Germany. The solicitation incorporates various FAR and DFARS clauses, including Buy American and Balance of Payments programs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Wholesale Supply

Integral Care

POSTED

2 days ago

DEADLINE

in about 1 month

AI Contract Overview

The contract involves the supply and delivery of drugs and placebos for the CATIS-ICAS research study, managed by Hamilton Health Sciences under the Government of Canada. This solicitation, identified as HHS0674 [BF-104767], was posted on April 20, 2026, with a response deadline set for May 1, 2026. The nature of the contract is focused on a federal level, with an emphasis on providing pharmaceutical products essential for the successful execution of the research study. Key details include the requirement for the vendor to furnish both active drugs and placebos, which are critical for the controlled aspects of the study. Though no specific NAICS code or set-aside type was indicated, the contracting authority is available for inquiries, reflecting a structured and formal procurement process. The contract supports research endeavors through timely and precise delivery of medical supplies that contribute to advancing clinical investigations within the health sciences sector.

General Info

Supply and delivery of drugs and placebos for CATIS-ICAS research by Hamilton Health Sciences.

Agency

Government of Canada → Hamilton Health Sciences

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedApr 20

Solicitation

Response DeadlineMay 1

Deadline has passed

Submission Closed

05/01/2026, 07:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Hamilton Health Sciences

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Hamilton Health Sciences

Office AddressN/A

Contacts

Contracting Authority

contact@example.gov

+1 (555) 000-0000

Full Description

https://hhsc.bonfirehub.ca/opportunities/104767

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 650+ contractors already using CLEATUS